Maybe because P 3 combo is for HAART resistant patients , estimate to be about 25,000 in USA , possibly FDA includes also patients with bad sides effects to HAART so they came with number of over 200,000 patients just for this study .
Well , imo it is good for CYDY .
I am just surprise why it took FDA such a long time to make this decision !!!